World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
23638
World Ranking
16166
National Ranking
1486

Michael Brada publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael Brada sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 310 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael Brada D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Brada sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael Brada is affiliated with the University of Liverpool in the United Kingdom. Their research primarily focuses on fields related to medicine, with an emphasis on radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, radiation, oncology, and epidemiology.

The scientist's main research topics cover lung cancer diagnosis and treatment, advanced radiotherapy techniques, effects of radiation exposure, medical imaging techniques and applications, pancreatic and hepatic oncology research, radiomics and machine learning in medical imaging, as well as meningioma and schwannoma management.

Michael Brada has contributed to several academic publications. Recent papers include:

  • "ESTRO ACROP guideline for target volume delineation of skull base tumors," 2020, Radiotherapy and Oncology
  • "Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters," 2022, Journal of Thoracic Oncology
  • "Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial," 2021, Journal of Neuro-Oncology
  • "Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer," 2021, Radiation Oncology
  • "Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study," 2020, Frontiers in Oncology

The scientist frequently collaborates with others in their field. Notable co-authors include:

  • John D. Fenwick
  • Helen Forbes
  • S. Ashley
  • Louise Turtle
  • Neeraj Bhalla

Michael Brada's work has been published repeatedly in several venues. Frequent publication journals include:

  • Journal of Thoracic Oncology
  • Radiotherapy and Oncology
  • Radiation Oncology
  • Journal of Neuro-Oncology
  • Frontiers in Oncology

Best Publications

  • A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

    W K A Yung;R E Albright;J Olson;R Fredericks

  • Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

    W. K.Alfred Yung;Michael D. Prados;Ricardo Yaya-Tur;Steven S. Rosenfeld

  • High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Stupp;M. Brada;M. J. van den Bent;J.-C. Tonn

  • Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

    M. Brada;D. Ford;S. Ashley;J. M. Bliss

  • Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.

    G. Minniti;D. Traish;S. Ashley;A. Gonsalves

  • The long‐term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas

    M. Brada;B. Rajan;D. Traish;S. Ashley

  • Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

    M. Brada;K. Hoang-Xuan;R. Rampling;P. Y. Dietrich

  • Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

    Riccardo Soffietti;Ufuk Abacioglu;Brigitta Baumert;Stephanie E Combs

  • High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Stupp;J.-C. Tonn;M. Brada;G. Pentheroudakis

  • Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial

    Sally Moore;Jessica Corner;Jo Haviland;Mary Wells

  • Craniopharyngioma — long-term results following limited surgery and radiotherapy

    B. Rajan;S. Ashley;C. Gorman;C.C. Jose

  • The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

    D. Osoba;N. K. Aaronson;M. Muller;K. Sneeuw

  • ESTRO-ACROP guideline "target delineation of glioblastomas"

    Maximilian Niyazi;Michael Brada;Anthony J Chalmers;Stephanie E Combs

  • Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

    M. Brada;L. Viviers;C. Abson;F. Hines

  • Relocatable frame for stereotactic external beam radiotherapy.

    S.S. Gill;D.G.T. Thomas;A.P. Warrington;M. Brada

  • Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma

    Michael Brada;Sally Stenning;Rhian Gabe;Lindsay C. Thompson

  • Health-Related Quality of Life in Patients Treated With Temozolomide Versus Procarbazine for Recurrent Glioblastoma Multiforme

    David Osoba;M. Brada;W. K.A. Yung;M. Prados

  • Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies.

    M Brada;I Judson;P Beale;S Moore

  • Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

    M. Bower;E. S. Newlands;N. M. Bleehen;M. Brada

  • Pathology and Genetics of Tumours of the Nervous System

    Michael Brada

Frequent Co-Authors

Stanley W. Ashley
Stanley W. Ashley Brigham and Women's Hospital
Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
Vincent Khoo
Vincent Khoo Royal Marsden NHS Foundation Trust
David Osoba
David Osoba University of British Columbia
Dirk De Ruysscher
Dirk De Ruysscher Maastricht University
Michael D. Prados
Michael D. Prados University of California, San Francisco
Michael Weller
Michael Weller University of Zurich
Ian Judson
Ian Judson Institute of Cancer Research
Douglas F. Easton
Douglas F. Easton University of Cambridge
Zoltan Szallasi
Zoltan Szallasi Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in healthcare alongside or beyond traditional medical studies, there are several accessible online degree options worth considering. For example, those seeking a nursing path might explore the easiest nursing schools to get into, which offer flexible entry requirements and may help you start your career faster.

Not everyone aiming to work in healthcare needs direct patient contact. Those interested in administrative or behind-the-scenes roles might consider medical billing and coding schools online with financial aid. These programs can open doors to in-demand positions that support medical facilities nationwide.

If testing requirements like the TEAS or HESI exams are a concern, it’s possible to find do i need to take the teas test for lpn – resources that explain which programs offer more flexible admissions criteria.

For those interested in management or leadership, pursuing a health care administration degree online can prepare you to oversee clinics, hospitals, or health systems. These degree pathways can expand your impact within the growing healthcare industry, all while studying from the comfort of your home.

Best Scientists Citing Michael Brada

Trending Scientists

Recently Published Articles